We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPG
526
DELISTED
Interpublic Group of Companies
IPG
$301K 0.03%
+15,420
New +$280K
TQNT
527
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
$301K 0.03%
19,025
-4,870
-20% -$72.1K
BMRN icon
528
BioMarin Pharmaceuticals
BMRN
$11.8B
$299K 0.03%
4,800
+1,800
+60% +$109K
EXC icon
529
Exelon
EXC
$48B
$299K 0.03%
11,495
-10,235
-47% -$261K
YHOO
530
DELISTED
Yahoo Inc
YHOO
$298K 0.03%
8,490
-8,100
-49% -$283K
AFL icon
531
Aflac
AFL
$65.5B
$296K 0.03%
9,500
-7,600
-44% -$237K
ANIK icon
532
Anika Therapeutics
ANIK
$214M
$296K 0.03%
6,385
-1,960
-23% -$87.2K
HES
533
DELISTED
Hess
HES
$296K 0.03%
2,990
-3,300
-52% -$298K
PRAA icon
534
PRA Group
PRAA
$671M
$296K 0.03%
4,967
– –
EFX icon
535
Equifax
EFX
$22B
$295K 0.03%
+4,060
New +$285K
MIG
536
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
$295K 0.03%
+40,980
New +$258K
FDO
537
DELISTED
FAMILY DOLLAR STORES
FDO
$295K 0.03%
+4,456
New +$269K
DXCM icon
538
DexCom
DXCM
$29B
$294K 0.03%
29,692
– –
SKT icon
539
Tanger
SKT
$4.79B
$294K 0.03%
8,410
– –
MRO
540
DELISTED
Marathon Oil Corporation
MRO
$293K 0.03%
7,330
-7,600
-51% -$280K
HSIC icon
541
Henry Schein
HSIC
$9.74B
$292K 0.03%
6,273
– –
OSUR icon
542
OraSure Technologies
OSUR
$273M
$292K 0.03%
33,881
– –
TYL icon
543
Tyler Technologies
TYL
$13.8B
$292K 0.03%
3,199
– –
CPB icon
544
Campbell Soup
CPB
$6.81B
$291K 0.03%
+6,356
New +$287K
HUM icon
545
Humana
HUM
$43.7B
$290K 0.03%
2,270
-1,700
-43% -$201K
IHS
546
DELISTED
IHS INC CL-A COM STK
IHS
$290K 0.03%
+2,140
New +$267K
CAH icon
547
Cardinal Health
CAH
$53.7B
$288K 0.03%
4,200
-11,449
-73% -$779K
MCHP icon
548
Microchip Technology
MCHP
$39B
$288K 0.03%
+11,800
New +$281K
FRM
549
DELISTED
FURMANITE CORPORATION COM
FRM
$286K 0.03%
24,563
-21,280
-46% -$224K
ACAD icon
550
Acadia Pharmaceuticals
ACAD
$4.49B
$283K 0.03%
12,537
-4,230
-25% -$88.3K
20 21
22
23 24

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.